ChiCTR2500106767 版本V1.0 版本创建时间2025/07/30 08:45:41 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500106767 

最近更新日期:

Date of Last Refreshed on:

2025-07-30 08:45:25 

注册时间:

Date of Registration:

2025-07-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

PEEP对非颅脑术后患者脑血流的影响: 一项观察性、生理性研究

Public title:

The impact of PEEP on cerebral blood flow in patients after non-cranial surgery: An observational and physiological study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

PEEP对非颅脑术后患者脑血流的影响: 一项观察性、生理性研究

Scientific title:

The impact of PEEP on cerebral blood flow in patients after non-cranial surgery: An observational and physiological study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

唐源 

研究负责人:

唐源 

Applicant:

Tang Yuan 

Study leader:

Tang Yuan 

申请注册联系人电话:

Applicant telephone:

+86 137 8701 5243

研究负责人电话:

Study leader's
telephone:

+86 137 8701 5243

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

626117021@qq.com

研究负责人电子邮件:

Study leader's E-mail:

626117021@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

乌鲁木齐市河南路118号

研究负责人通讯地址:

乌鲁木齐市河南路118号

Applicant address:

No. 118, Henan Road, Urumqi

Study leader's address:

No. 118, Henan Road, Urumqi

申请注册联系人邮政编码:

Applicant postcode:

831000

研究负责人邮政编码:

Study leader's postcode:

831000

申请人所在单位:

新疆医科大学第五附属医院

Applicant's institution:

Xinjiang Medical University Fifth Affiliated Hospital

研究负责人所在单位:

新疆医科大学第五附属医院

Affiliation of the Leader:

Xinjiang Medical University Fifth Affiliated Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

XYDWFYLSK-2025-184

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新疆医科大学第五附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Fifth Affiliated Hospital of Xinjiang Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-07-17 00:00:00

伦理委员会联系人:

高静

Contact Name of the ethic committee:

Gao Jing

伦理委员会联系地址:

乌鲁木齐市河南路118号

Contact Address of the ethic committee:

No. 118, Henan Road, Urumqi

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 991 759 8453

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新疆医科大学第五附属医院

Primary sponsor:

Xinjiang Medical University Fifth Affiliated Hospital

研究实施负责(组长)单位地址:

乌鲁木齐市河南路118号

Primary sponsor's address:

No. 118, Henan Road, Urumqi

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

新疆维吾尔自治区

市(区县):

乌鲁木齐市

Country:

China

Province:

Xinjiang Uygur Autonomous Region

City:

Urumqi

单位(医院):

新疆医科大学第五附属医院

具体地址:

乌鲁木齐市河南路118号

Institution
hospital:

Xinjiang Medical University Fifth Affiliated Hospital

Address:

No. 118, Henan Road, Urumqi

经费或物资来源:

自筹

Source(s) of funding:

raise independently

研究疾病:

非颅脑术后患者脑血流  

Target disease:

Cerebral blood flow in patients after non-cranial surgery

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

PEEP对非颅脑术后患者脑血流的影响:一项观察性、生理性研究  

Objectives of Study:

The impact of PEEP on cerebral blood flow in patients after non-cranial surgery: An observational and physiological study

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄≥18岁,非颅脑手术(如胸腹腔手术、骨科手术等)后转入ICU; (2)机械通气且预计通气时间≥6小时; (3)同意并签署知情同意书;

Inclusion criteria

(1) Aged >=18 years, transferred to ICU after non-cranial surgery (such as thoracic and abdominal surgery, orthopedic surgery, etc.); (2) Mechanical ventilation with an expected ventilation duration of >=6 hours; (3) Agree and sign the informed consent form.

排除标准:

(1)颅骨缺损或TCD声窗穿透不良; (2)严重循环衰竭(去甲肾上腺素剂量≥0.3μg/kg/min); (3)颅内出血、脑梗死; (4)腹腔室间隔综合征; (5)氧合指数小于150mmHg; (6)妊娠; (7)气胸、纵膈气肿、肺大泡; (8)未签署知情同意书。

Exclusion criteria:

(1) Skull defect or poor penetration of TCD acoustic window; (2) Severe circulatory failure (norepinephrine dose >= 0.3 μg/kg/min); (3) Intracranial hemorrhage, cerebral infarction; (4) Abdominal compartment syndrome; (5) Oxygenation index less than 150mmHg; (6) Pregnancy; (7) Pneumothorax, mediastinal emphysema, pulmonary bulla; (8) Failure to sign the informed consent form.

研究实施时间:

Study execute time:

From 2025-08-01 00:00:00 To 2026-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-08-01 00:00:00 To 2026-02-28 00:00:00

干预措施:

Interventions:

组别:

Case series

样本量:

55

Group:

Case series

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

新疆维吾尔自治区  

市(区县):

乌鲁木齐市 

Country:

China

Province:

Xinjiang Uygur Autonomous Region

City:

Urumqi

单位(医院):

新疆医科大学第五附属医院 

单位级别:

三甲 

Institution
hospital:

Xinjiang Medical University Fifth Affiliated Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

大脑中动脉PSV

指标类型:

主要指标

Outcome:

PSV of middle cerebral artery

Type:

Primary indicator

测量时间点:

测量方法:

TCD

Measure time point of outcome:

Measure method:

TCD

指标中文名:

大脑中动脉PI

指标类型:

主要指标

Outcome:

PI of middle cerebral artery

Type:

Primary indicator

测量时间点:

测量方法:

TCD

Measure time point of outcome:

Measure method:

TCD

指标中文名:

大脑中动脉RI

指标类型:

主要指标

Outcome:

RI of middle cerebral artery

Type:

Primary indicator

测量时间点:

测量方法:

TCD

Measure time point of outcome:

Measure method:

TCD

指标中文名:

血气分析

指标类型:

次要指标

Outcome:

blood gas analysis

Type:

Secondary indicator

测量时间点:

测量方法:

血气分析仪

Measure time point of outcome:

Measure method:

blood gas analyzer

指标中文名:

血压

指标类型:

次要指标

Outcome:

blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

动脉监测

Measure time point of outcome:

Measure method:

Arterial monitoring

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

none

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-07-30 08:45:25